Researchers Raise Concerns about Faster Aging, Possible Early-Onset Dementia, for Children and Young Adult Cancer Survivors
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to…
RNA Splicing Errors Drive Leukemia
By: Staff Writer | January 02, 2026 | 7 min. read | Share Summary A new study from Sylvester Comprehensive…
Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer-driving protein…
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with…
Young donor age proves critical for survival after stem cell transplantation
The selection of suitable donors is crucial for the long-term recovery of patients after an allogeneic hematopoietic stem…
Immune cell dysregulation and inflammatory mediators shape epilepsy risk
Background and objectives Emerging evidence implicates immune dysregulation and neuroinflammation in the pathogenesis of epilepsy, yet the causal…
IGF2BP3 protein drives leukemia growth by linking metabolism and RNA control
Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA…
Medical imaging radiation linked to small cancer risk in children
A recent study links exposure to radiation from medical imaging to a small-but-significant risk of blood cancers among…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
Daily use of low-dose colchicine may slow growth of blood mutations linked to disease
Taking low-dose colchicine daily may slow the progression of a common acquired gene mutation found in the blood…
New method uncovers how extracellular vesicles impact immune response in cancer
Certain types of biochemical processes can impair the immune system’s ability to recognize and kill cancer cells. Purdue…